SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution von Miller, Christopher A, White, Brian S, Dees, Nathan D, Griffith, Malachi, Welch, John S, Griffith, Obi L, Vij, Ravi, Tomasson, Michael H, Graubert, Timothy A, Walter, Matthew J, Ellis, Matthew J, Schierding, William, DiPersio, John F, Ley, Timothy J, Mardis, Elaine R, Wilson, Richard K, Ding, Li

Volltext

Mutational landscape and significance across 12 major cancer types von Kandoth, Cyriac, McLellan, Michael D., Vandin, Fabio, Ye, Kai, Niu, Beifang, Lu, Charles, Xie, Mingchao, Zhang, Qunyuan, McMichael, Joshua F., Wyczalkowski, Matthew A., Leiserson, Mark D. M., Miller, Christopher A., Welch, John S., Walter, Matthew J., Wendl, Michael C., Ley, Timothy J., Wilson, Richard K., Raphael, Benjamin J., Ding, Li

Volltext

Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy von Martino, Orsola di, Welch, John S

Volltext

A sheep in wolf's clothing? Wild-type P53 disguises as mutant to promote leukemogenesis von Ferris, Margaret A, Welch, John S

Volltext

CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression von Spencer, David H., Russler-Germain, David A., Ketkar, Shamika, Helton, Nichole M., Lamprecht, Tamara L., Fulton, Robert S., Fronick, Catrina C., O’Laughlin, Michelle, Heath, Sharon E., Shinawi, Marwan, Westervelt, Peter, Payton, Jacqueline E., Wartman, Lukas D., Welch, John S., Wilson, Richard K., Walter, Matthew J., Link, Daniel C., DiPersio, John F., Ley, Timothy J.

Volltext

TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies von Ruzinova, Marianna B, Lee, Yi-Shan, Duncavage, Eric J, Welch, John S

Volltext

Acute Myeloid Leukemia: The Good, the Bad, and the Ugly von Kuykendall, Andrew, Duployez, Nicolas, Boissel, Nicolas, Lancet, Jeffrey E, Welch, John S

Volltext

Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML von Wong, Terrence N., Miller, Christopher A., Klco, Jeffery M., Petti, Allegra, Demeter, Ryan, Helton, Nichole M., Li, Tiandao, Fulton, Robert S., Heath, Sharon E., Mardis, Elaine R., Westervelt, Peter, DiPersio, John F., Walter, Matthew J., Welch, John S., Graubert, Timothy A., Wilson, Richard K., Ley, Timothy J., Link, Daniel C.

Volltext

RXRA DT448/9PP generates a dominant active variant capable of inducing maturation in acute myeloid leukemia cells von Di Martino, Orsola, Ferris, Margaret A, Hadwiger, Gayla, Sarkar, Soyi, Vu, Anh, Menéndez-Gutiérrez, María P, Ricote, Mercedes, Welch, John S

Volltext

Molecular responses in decitabine- and decitabine/ venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromes von Gruszczynska, Agata, Maiti, Abhishek, Miller, Christopher A, Ramakrishnan, Sai Mukund, Link, Daniel C, Uy, Geoffrey L, Petti, Allegra A, Hayes, Kala, DiNardo, Courtney D, Ravandi, Farhad, Ley, Timothy J, Spencer, David H, Gao, Feng, Konopleva, Marina Y, Welch, John S

Volltext

Endogenous and combination retinoids are active in myelomonocytic leukemias von Di Martino, Orsola, Niu, Haixia, Hadwiger, Gayla, Kuusanmaki, Heikki, Ferris, Margaret A, Vu, Anh, Beales, Jeremy, Wagner, Carl, Menéndez-Gutiérrez, María P, Ricote, Mercedes, Heckman, Caroline, Welch, John S

Volltext

Expanding dasatinib beyond KIT in acute myeloid leukemia von Welch, John S

Volltext

Patterns of mutations in TP53 mutated AML von Welch, John S.

Volltext

Decitabine salvage for TP53 -mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy von Ferraro, Francesca, Gruszczynska, Agata, Ruzinova, Marianna B, Miller, Christopher A, Percival, Mary Elizabeth, Uy, Geoffrey L, Pusic, Iskra, Jacoby, Meagan A, Christopher, Mathew J, Kim, Miriam Y, Westervelt, Peter, Cashen, Amanda F, Schroeder, Mark A, DiPersio, John F, Abboud, Camille N, Wartman, Lukas D, Gao, Feng, Link, Daniel C, Ley, Timothy J, Welch, John S

Volltext

TP53 and the star-crossed lovers MDS and AML von Welch, John S.

Volltext

Endogenous retinoid X receptor ligands in mouse hematopoietic cells von Niu, Haixia, Fujiwara, Hideji, di Martino, Orsola, Hadwiger, Gayla, Frederick, Thomas E, Menéndez-Gutiérrez, María P, Ricote, Mercedes, Bowman, Gregory R, Welch, John S

Volltext

Serendipity: decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia von Abboud, Ramzi, Han, Se Young, Duncavage, Eric J, Cashen, Amanda F, Shirai, Cara Lunn, Welch, John S, DiPersio, John F, Abboud, Camille N

Volltext

PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice von Welch, John S, Yuan, Wenlin, Ley, Timothy J

Volltext

Exome analysis of treatment‐related AML after APL suggests secondary evolution von Wang, Tianjiao, Jacoby, Meagan A., Duncavage, Eric J., Miller, Christopher A., Heath, Sharon, Rahme, Ramy, Fenaux, Pierre, Ades, Lionel, Renneville, Aline, Cassinat, Bruno, Takeshita, Akihiro, Asou, Norio, Miyazaki, Yasushi, Kiyoi, Hitoshi, Ravandi, Farhad, Westervelt, Peter, Wartman, Lukas D., Welch, John S.

Volltext

Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow von Bansal, Dhruv, Vij, Kiran, Chang, Gue Su, Miller, Christopher A, DiPersio, John F, Vij, Ravi, Heath, Sharon E, Westervelt, Peter, Welch, John S, Fehniger, Todd A

Volltext